© 2021 MJH Life Sciences and Diagnostic Imaging. All rights reserved.
© 2021 MJH Life Sciences™ and Diagnostic Imaging. All rights reserved.
February 28, 2021
Radiologists may not order a DBT exam for African American patients, but they can participate in improving access to the screening.
February 25, 2021
For women who do not have easy access to mammography, clinical breast examination has been shown to increase breast cancer detection and save lives.
February 24, 2021
The approach, based on ACR guidance, is intended to promote vaccine use while reducing patient anxiety and unnecessary imaging.
February 23, 2021
While digital breast tomosynthesis improves cancer detection and recall rates among women of all ages and races, significantly fewer African American women have access to the exam.
February 19, 2021
Women with less education, with lower income, or from racial and ethnic minority groups have less access to 3D mammography and the potential benefits it provides.
Mammography "Sweet Spot" Recall Rate; MRI for Early-Stage Testicular Cancer Follow-Up; COVID-19 and Body Self-Attack; Plus, Global Radiology
February 14, 2021
The currently acceptable 12 percent-to-14 percent recall rate is too high to maximize cancer detection and minimize biopsies and unnecessary follow-up studies.
February 12, 2021
COVID-19 Vaccine-Related Adenopathies on Breast MRI; Baseline Mammography at 40; Cherenkov Imaging to Improve Radiation Therapy Improvement; and Sexual Harassment and Gender Discrimination in Radiology
February 09, 2021
Study shows that baseline mammography screening to identify breast density, starting at age 40, is cost-effective.
After more than two decades, women between ages 20 and 39 are seeing a slight increase in the rates of breast cancer mortality.